ReviewFrontiers in oral health2025
Endodontic bioceramics: current and futurity aspects.
Review in Frontiers in oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regenerative endodontic treatment for premolars with apical root segment separation and extensive periapical lesions secondary to severe inflammatory root resorption: A report of two cases.Experimental and therapeutic medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excellent bioactivity and biocompatibility make bioceramics a popular choice in dentistry, especially in endodontics. The most commonly utilised bioceramic in endodontics is mineral trioxide aggregate (MTA). Several emerging bioceramics showed promise for endodontic treatment. This study discusses bioceramics and their use in endodontic treatments like as root-end filling, root canal therapy, vital pulp therapy, apexification/regenerative endodontic treatment, perforation repair, and root defect repair. The applicable research from 1990 to 2023 was screened using keywords in PubMed and Web of Science. According to current research, MTA in the management of endodontic disease is well supported. New bioceramics including Biodentine, EndoSequence, and calcium-enriched mixes have demonstrated encouraging clinical results, but additional controlled trials must be conducted to establish their use in endodontics. To address endodontic problems, bioceramics must be improved for their biologic activity, including antibacterial activity, mechanical qualities, and reduced setting time and solubility. The purpose of this review is to provide an overview of the state of bioceramic technology and to investigate potential avenues for further investigation to improve its regenerative and therapeutic potential in endodontics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.